Juergen Swienty-Busch

2 weeks ago | drugdiscoveryonline.com | Mark Witcher |Ryan Littich |Juergen Swienty-Busch |David Lyon

Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient. Utilizing A Stepwise Approach For Nitrosamine Risk MitigationThe following insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.